As AI promises to accelerate drug development, a critical question emerges: can pharmaceutical manufacturing keep pace? In this episode, Martin Wood and Adrian La Porta examine how artificial intelligence could transform the entire pharmaceutical value chain, from quality control paradigms to facility design. Recorded as a preview to Bryden Wood's Accelerate Pharmaceuticals event on 25th November, the discussion explores fundamental questions about the future of drug manufacturing. Adrian arg...
All content for Built Environment Matters is the property of Bryden Wood and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
As AI promises to accelerate drug development, a critical question emerges: can pharmaceutical manufacturing keep pace? In this episode, Martin Wood and Adrian La Porta examine how artificial intelligence could transform the entire pharmaceutical value chain, from quality control paradigms to facility design. Recorded as a preview to Bryden Wood's Accelerate Pharmaceuticals event on 25th November, the discussion explores fundamental questions about the future of drug manufacturing. Adrian arg...
AI Edge Revolution: How Data Centres are Reshaping for AI Service Serving a Vertical Need | Emmanuel Becker
Built Environment Matters
37 minutes
4 months ago
AI Edge Revolution: How Data Centres are Reshaping for AI Service Serving a Vertical Need | Emmanuel Becker
The data centre industry is experiencing unprecedented disruption. As AI applications drive explosive demand for computing power, traditional approaches to data centre design and deployment are becoming obsolete almost overnight. In this episode, Emmanuel Becker, CEO of Mediterra Datacenters, shares insights from his extensive career spanning the evolution from on-premise to cloud to AI-driven infrastructure. With NVIDIA releasing new GPU generations every 6-12 months, data centre operators f...
Built Environment Matters
As AI promises to accelerate drug development, a critical question emerges: can pharmaceutical manufacturing keep pace? In this episode, Martin Wood and Adrian La Porta examine how artificial intelligence could transform the entire pharmaceutical value chain, from quality control paradigms to facility design. Recorded as a preview to Bryden Wood's Accelerate Pharmaceuticals event on 25th November, the discussion explores fundamental questions about the future of drug manufacturing. Adrian arg...
